Total Payments
$15,765
2024 Payments
$6,735
Companies
27
Transactions
713
Medicare Patients
2,400
Medicare Billing
$165,004
Payment Breakdown by Category
Food & Beverage$14,444 (91.6%)
Consulting$800.00 (5.1%)
Education$520.97 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,444 | 704 | 91.6% |
| Consulting Fee | $800.00 | 1 | 5.1% |
| Education | $520.97 | 8 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,166 | 145 | $0 (2024) |
| Janssen Biotech, Inc. | $1,350 | 53 | $0 (2024) |
| PFIZER INC. | $1,161 | 63 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,074 | 40 | $0 (2024) |
| UCB, Inc. | $1,019 | 28 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $824.44 | 106 | $0 (2024) |
| GENZYME CORPORATION | $786.92 | 37 | $0 (2024) |
| Lilly USA, LLC | $716.41 | 31 | $0 (2024) |
| Dermavant Sciences, Inc. | $641.35 | 23 | $0 (2024) |
| Amgen Inc. | $615.12 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,735 | 307 | ABBVIE INC. ($1,556) |
| 2023 | $4,095 | 180 | ABBVIE INC. ($789.41) |
| 2022 | $2,816 | 126 | ABBVIE INC. ($1,070) |
| 2021 | $2,120 | 100 | AbbVie Inc. ($751.06) |
All Payment Transactions
713 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.61 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.90 | General |
| 12/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.69 | General |
| Category: Immunology | ||||||
| 12/17/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Inflammation & Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.54 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $69.87 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.59 | General |
| Category: Immunology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.46 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.29 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.45 | General |
| Category: Immunology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $29.54 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.73 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $33.69 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 960 | 1,477 | $192,060 | $62,523 |
| 2022 | 14 | 813 | 1,189 | $174,485 | $55,978 |
| 2021 | 14 | 591 | 910 | $129,840 | $43,994 |
| 2020 | 2 | 36 | 36 | $6,777 | $2,509 |
Total Patients
2,400
Total Services
3,612
Medicare Billing
$165,004
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 201 | 269 | $42,893 | $14,509 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 147 | $33,144 | $11,847 | 35.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 127 | 146 | $29,574 | $9,841 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $18,534 | $6,054 | 32.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 90 | 90 | $17,862 | $5,451 | 30.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 111 | 142 | $16,963 | $4,465 | 26.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 77 | 80 | $14,498 | $4,374 | 30.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 72 | 407 | $4,829 | $1,738 | 36.0% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 32 | 33 | $5,381 | $1,338 | 24.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 24 | 24 | $3,071 | $958.82 | 31.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 24 | $2,397 | $902.16 | 37.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 15 | $1,526 | $535.44 | 35.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 13 | 15 | $1,347 | $489.97 | 36.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 22 | $41.56 | $18.65 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 171 | $38,798 | $13,071 | 33.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 112 | 147 | $30,194 | $10,581 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 110 | 143 | $23,043 | $7,727 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 74 | 74 | $22,341 | $7,020 | 31.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 87 | 87 | $17,607 | $5,473 | 31.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 70 | 75 | $13,911 | $4,245 | 30.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 81 | 96 | $11,674 | $2,708 | 23.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 58 | 235 | $2,809 | $975.75 | 34.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 24 | 24 | $3,176 | $962.79 | 30.3% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2022 | 19 | 23 | $3,750 | $883.47 | 23.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 22 | 26 | $2,617 | $836.91 | 32.0% |
About Patrick Jameson, PA-C
Patrick Jameson, PA-C is a Physician Assistant healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/11/2019. The National Provider Identifier (NPI) number assigned to this provider is 1538707393.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Patrick Jameson, PA-C has received a total of $15,765 in payments from pharmaceutical and medical device companies, with $6,735 received in 2024. These payments were reported across 713 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($14,444).
As a Medicare-enrolled provider, Jameson has provided services to 2,400 Medicare beneficiaries, totaling 3,612 services with total Medicare billing of $165,004. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Las Vegas, NV
- Active Since 12/11/2019
- Last Updated 09/24/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1538707393
Products in Payments
- SKYRIZI (Biological) $1,924
- RINVOQ (Biological) $1,719
- TREMFYA (Drug) $1,482
- DUPIXENT (Biological) $1,192
- Sotyktu (Drug) $792.83
- EUCRISA (Drug) $719.80
- VTAMA (Drug) $641.35
- TALTZ (Drug) $600.83
- Bimzelx (Biological) $567.27
- ILUMYA (Biological) $517.80
- HUMIRA (Biological) $490.40
- ADBRY (Biological) $477.77
- Enbrel (Biological) $400.20
- Cimzia (Drug) $397.16
- OPZELURA (Drug) $391.97
- CIBINQO (Drug) $360.46
- Zoryve (Drug) $301.88
- Otezla (Drug) $214.92
- Odomzo (Drug) $197.06
- COSENTYX (Biological) $178.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Las Vegas
Steven Hawkes, Pa, PA
Physician Assistant — Payments: $37,914
Physician Assistant $37,914
Nathan Morgan, Pa-C, PA-C
Physician Assistant — Payments: $35,090
Physician Assistant $35,090
Stephanie Dastrup, Pa-C, PA-C
Physician Assistant — Payments: $22,745
Physician Assistant $22,745
Jordan Christensen, Pa-C, PA-C
Physician Assistant — Payments: $18,606
Physician Assistant $18,606
Sandra Oviedo, Pa, PA
Physician Assistant — Payments: $15,629
Physician Assistant $15,629
Jacquelyn Daneshforouz, Physician Assistant, PHYSICIAN ASSISTANT
Physician Assistant — Payments: $13,402
Physician Assistant $13,402